Etrat Hooshmandi

Dr. Etrat Hooshmandi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
Sachchida Nand RaiSachchida Nand Rai
Sachchida Nand Rai
NTNeeraj Tiwari
Neeraj Tiwari
PSPayal Singh
Payal Singh
ASAnurag Kumar Singh
Anurag Kumar Singh
DMDivya Mishra
Divya Mishra
Mohan Prasad SinghMohan Prasad Singh
Mohan Prasad Singh
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a human coronavirus (HCoV) that has created a pandemic situation worldwide as COVID‐19. This virus can invade human cells via angiotensin‐converting enzyme 2 (ACE2) receptor‐based mechanisms, affecting the human respiratory tract. However, several reports of neurological symptoms suggest a neuroinvasive development of coronavirus. SARS‐CoV‐2 can damage the brain via several routes, along with direct neural cell infection with the coronavirus. The chronic inflammatory reactions surge the brain with proinflammatory elements, damaging the neural cells, causing brain ischemia associated with other health issues. SARS‐CoV‐2 exhibited neuropsychiatric and neurological manifestations, including cognitive impairment, depression, dizziness, delirium, and disturbed sleep. These symptoms show nervous tissue damage that enhances the occurrence of neurodegenerative disorders and aids dementia. SARS‐CoV‐2 has been seen in brain necropsy and isolated from the cerebrospinal fluid of COVID‐19 patients. The associated inflammatory reaction in some COVID‐19 patients has increased proinflammatory cytokines, which have been investigated as a prognostic factor. Therefore, the immunogenic changes observed in Parkinson’s and Alzheimer’s patients include their pathogenetic role. Inflammatory events have been an important pathophysiological feature of neurodegenerative diseases (NDs) such as Parkinson’s and Alzheimer’s. The neuroinflammation observed in AD has exacerbated the Aβ burden and tau hyperphosphorylation. The resident microglia and other immune cells are responsible for the enhanced burden of Aβ and subsequently mediate tau phosphorylation and ultimately disease progression. Similarly, neuroinflammation also plays a key role in the progression of PD. Several studies have demonstrated an interplay between neuroinflammation and pathogenic mechanisms of PD. The dynamic proinflammation stage guides the accumulation of α‐synuclein and neurodegenerative progression. Besides, few viruses may have a role as stimulators and generate a cross‐autoimmune response for α‐synuclein. Hence, neurological complications in patients suffering from COVID‐19 cannot be ruled out. In this review article, our primary focus is on discussing the neuroinvasive effect of the SARS‐CoV‐2 virus, its impact on the blood‐brain barrier, and ultimately its impact on the people affected with neurodegenerative disorders such as Parkinson’s and Alzheimer’s.

22 February 2021 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
VOVahid Reza Ostovan
Vahid Reza Ostovan
RFRazieh Foroughi
Razieh Foroughi
MRMahtab Rostami
Mahtab Rostami
MAMostafa Almasi-Dooghaee
Mostafa Almasi-Dooghaee
MEManouchehr Esmaili
Manouchehr Esmaili
ABAfshin Borhani-Haghighi
Afshin Borhani-Haghighi

1 September 2018 in Neuroscience
Verified
Journal Article
Closed access
Etrat HooshmandiEtrat Hooshmandi
Etrat Hooshmandi
FMFereshteh Motamedi
Fereshteh Motamedi
MMMaryam Moosavi
Maryam Moosavi
HKHermann Katinger
Hermann Katinger
ZZZahra Zakeri
Zahra Zakeri
NMNader Maghsoudi
Nader Maghsoudi

24 November 2018 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
Etrat HooshmandiEtrat Hooshmandi
Etrat Hooshmandi
RGRasoul Ghasemi
Rasoul Ghasemi
PIParisa Iloun
Parisa Iloun
MMMaryam Moosavi
Maryam Moosavi

9 August 2018 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
LSLeila Simani
Leila Simani
FRFari Ryan
Fari Ryan
SHShadab Hashemifard
Shadab Hashemifard
Etrat HooshmandiEtrat Hooshmandi
Etrat Hooshmandi
MMMaryam Madahi
Maryam Madahi
MRMahtab Ramezani
Mahtab Ramezani

1 April 2020 in Behavioural Brain Research
Verified
Journal Article
Closed access
MMMaryam Moosavi
Maryam Moosavi
Etrat HooshmandiEtrat Hooshmandi
Etrat Hooshmandi
PJPegah Javadpour
Pegah Javadpour
NMNader Maghsoudi
Nader Maghsoudi
HKHermann Katinger
Hermann Katinger
RGRasoul Ghasemi
Rasoul Ghasemi